Condition: Crohns Disease · Sponsor: Alimentiv Inc.
To date, patients with Crohn's Disease (CD) and permanent ileostomies have been excluded from clinical trials for new treatments. To allow this patient population to be included in clinical trials, outcome and measurement tools are needed. This study aims to develop a Patient Reported Outcome (PRO) and Endoscopic Index (EI) for patients with Crohn's Disease (CD) and permanent ileostomy. The study will enroll about 50 participants and collect videos of endoscopies that are done as part of standard of care. The videos will be centrally read to identify features that represent a broad range of inflammation and will be used to develop the EI. Participants will also be asked to participate in interviews, to understand the symptoms and impacts that are most important to participants for the development of a PRO.
This description comes directly from the study's public registry record.
Ana Olteanu · 416-704-7734 · ana.olteanu@alimentiv.com
Robyn Garrels-Lierman · 642-204-2047 · robyn.garrels@alimentiv.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic- Rochester | Rochester, Minnesota, United States | Recruiting |
| Washington University in St Louis School of Medicine | St Louis, Missouri, United States | Recruiting |
| Cleveland Clinic Foundation | Cleveland, Ohio, United States | Recruiting |
| McMaster University Medical Centre | Hamilton, Ontario, Canada | Recruiting |
| LHSC - University Campus | London, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06670638